• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基磷灰石晶体生长抑制剂:一种恒定组成方法。

Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.

作者信息

Wilson J W, Werness P G, Smith L H

出版信息

J Urol. 1985 Dec;134(6):1255-8. doi: 10.1016/s0022-5347(17)47706-8.

DOI:10.1016/s0022-5347(17)47706-8
PMID:2997488
Abstract

Pyrophosphate, citrate and magnesium, inhibitors of hydroxyapatite crystal growth, were studied using a seeded crystal growth system of constant composition at pH 5.80, 6.60 and 7.40. With this technique, crystal growth was studied at constant supersaturation at different pH values without the induction of other calcium phosphate phases. One inhibitor unit (that concentration of material that results in a reduction of 50 per cent in the growth rate from control) was calculated using the Langmuir adsorption isotherm. Pyrophosphate and citrate increased inhibitor activity with decreasing pH, whereas magnesium increased inhibitor activity with increasing pH. These data suggest that, at the urinary concentrations of these inhibitors, pyrophosphate is the most potent inhibitor, citrate less, and magnesium least. Pooled urine collections were studied using the same system and were found to have decreased inhibitor activity as pH decreased. This suggests that other modulators of hydroxyapatite, either promoters or inhibitors, are active in this system at the pH values studied.

摘要

使用恒定组成的晶种生长系统,在pH值为5.80、6.60和7.40的条件下,对羟基磷灰石晶体生长的抑制剂焦磷酸盐、柠檬酸盐和镁进行了研究。采用该技术,在不同pH值下的恒定过饱和度条件下研究晶体生长,而不诱导其他磷酸钙相。使用朗缪尔吸附等温线计算一个抑制剂单位(即导致生长速率比对照降低50%的物质浓度)。焦磷酸盐和柠檬酸盐随着pH值降低而增加抑制剂活性,而镁随着pH值升高而增加抑制剂活性。这些数据表明,在这些抑制剂的尿液浓度下,焦磷酸盐是最有效的抑制剂,柠檬酸盐次之,镁最少。使用相同系统对混合尿液样本进行了研究,发现随着pH值降低,抑制剂活性降低。这表明在研究的pH值下,羟基磷灰石的其他调节剂,无论是促进剂还是抑制剂,在该系统中都具有活性。

相似文献

1
Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.羟基磷灰石晶体生长抑制剂:一种恒定组成方法。
J Urol. 1985 Dec;134(6):1255-8. doi: 10.1016/s0022-5347(17)47706-8.
2
The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.尿液、焦磷酸盐、柠檬酸盐、镁及糖胺聚糖对草酸钙晶体体外生长和聚集的影响。
Clin Chim Acta. 1981 May;112(3):349-56. doi: 10.1016/0009-8981(81)90458-7.
3
Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.磷酸二钙二水合物与羟基磷灰石尿结晶抑制剂之间的协同作用。
Int Urol Nephrol. 2002;34(4):447-51. doi: 10.1023/a:1025671019653.
4
The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
Urol Res. 1989;17(3):153-5. doi: 10.1007/BF00256242.
5
Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.一水合草酸钙体外结晶动力学的调控
Kidney Int. 1988 Sep;34(3):346-50. doi: 10.1038/ki.1988.187.
6
Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine.尿液中草酸钙结晶的调节剂。I. 使用人工尿液的连续结晶器研究。
J Urol. 1986 Jun;135(6):1322-6. doi: 10.1016/s0022-5347(17)46084-8.
7
Urolithiasis inhibitors and calculus nucleation.尿路结石抑制剂与结石成核
Urol Res. 1989;17(3):163-6. doi: 10.1007/BF00256244.
8
Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.影响二水合草酸钙碎结石再生长的因素。
BMC Urol. 2006 Jul 5;6:16. doi: 10.1186/1471-2490-6-16.
9
Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.镁、柠檬酸盐和植酸盐混合物作为尿液草酸钙结晶抑制剂的功效。
J Urol. 2015 Sep;194(3):812-9. doi: 10.1016/j.juro.2015.03.099. Epub 2015 Mar 26.
10
Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities.复发性含钙结石患者中低枸橼酸尿症和低焦磷酸盐尿症的患病率:作为孤立缺陷或与其他代谢异常相关。
Nephron. 1990;56(4):379-86. doi: 10.1159/000186179.

引用本文的文献

1
Age-related changes in cationic compositions of human cranial base bone apatite measured by X-ray energy dispersive spectroscopy (EDS) coupled with scanning electron microscope (SEM).通过与扫描电子显微镜(SEM)联用的X射线能量色散光谱(EDS)测量的人颅底骨磷灰石阳离子组成的年龄相关变化。
Biometals. 2022 Oct;35(5):1077-1094. doi: 10.1007/s10534-022-00425-1. Epub 2022 Aug 4.
2
Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.枸橼酸钾与柠檬酸对磷酸钙结石形成者尿路结石风险的影响。
J Urol. 2018 Dec;200(6):1278-1284. doi: 10.1016/j.juro.2018.07.039. Epub 2018 Jul 20.
3
Does drinking water influence hospital-admitted sialolithiasis on an epidemiological level in Denmark?
在丹麦,饮水在流行病学层面上会影响住院治疗的涎石病吗?
BMJ Open. 2015 May 3;5(4):e007385. doi: 10.1136/bmjopen-2014-007385.
4
On the origin of calcium oxalate monohydrate papillary renal stones.关于一水草酸钙肾乳头结石的起源
Urolithiasis. 2015 Jan;43 Suppl 1:33-9. doi: 10.1007/s00240-014-0697-5. Epub 2014 Aug 3.
5
Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study.肾乳头钙化与一水草酸钙单水结晶肾乳头结石的形成:一项病例系列研究。
BMC Urol. 2013 Mar 11;13:14. doi: 10.1186/1471-2490-13-14.
6
Nanoparticle-based test measures overall propensity for calcification in serum.基于纳米颗粒的检测方法可测量血清中总体的钙化倾向。
J Am Soc Nephrol. 2012 Oct;23(10):1744-52. doi: 10.1681/ASN.2012030240. Epub 2012 Sep 6.
7
Factors modulating the pH at which calcium and magnesium phosphates precipitate from human urine.调节磷酸钙和磷酸镁从人尿中沉淀时的pH值的因素。
Urol Res. 2005 Aug;33(4):254-60. doi: 10.1007/s00240-004-0458-y.
8
Adherence of urease-induced crystals to rat bladder epithelium.脲酶诱导的晶体对大鼠膀胱上皮的黏附。
Urol Res. 1988;16(1):49-52. doi: 10.1007/BF00264628.
9
The effects of fractioned human urine on urease-induced crystallisation in vitro.分次收集的人尿液对体外脲酶诱导结晶的影响。
Urol Res. 1990;18(1):35-8. doi: 10.1007/BF00294579.
10
A simple technique for studying struvite crystal growth in vitro.一种用于体外研究鸟粪石晶体生长的简单技术。
Urol Res. 1990;18(1):39-43. doi: 10.1007/BF00294580.